Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea
Jun Hyeong Seo, Soo Young Jeong, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi
Obstet Gynecol Sci. 2019;62(6):411-419.   Published online 2019 Oct 11     DOI:
Citations to this article as recorded by Crossref logo
The expression and mutation of BRCA1/2 genes in ovarian cancer: a global systematic study
Dinh-Toi Chu, Mai Vu Ngoc Suong, Hue Vu Thi, Thuy-Duong Vu, Manh-Hung Nguyen, Vijai Singh
Expert Review of Molecular Diagnostics.2023; 23(1): 53.     CrossRef
Survival outcomes in patients withBRCAmutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors
Lucia Musacchio, Serena Boccia, Claudia Marchetti, Angelo Minucci, Floriana Camarda, Chiara Cassani, Jole Ventriglia, Vanda Salutari, Viola Ghizzoni, Elena Giudice, Maria Teresa Perri, Maria Vittoria Carbone, Caterina Ricci, Sandro Pignata, Anna Fagotti,
International Journal of Gynecologic Cancer.2023; 33(6): 922.     CrossRef
Grounding and Deepening Academic Writing in Human Resource Development: The Role of Selecting and Representing the Supporting Literature
K. Peter Kuchinke
Human Resource Development Review.2023; 22(3): 414.     CrossRef
Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis
Vera M. Witjes, Majke H.D. van Bommel, Marjolijn J.L. Ligtenberg, Janet R. Vos, Marian J.E. Mourits, Margreet G.E.M. Ausems, Joanne A. de Hullu, Tjalling Bosse, Nicoline Hoogerbrugge
Gynecologic Oncology.2022; 164(1): 221.     CrossRef
Germline mutations in Chinese ovarian cancer with or without breast cancer
Ava Kwong, Cecilia Yuen Sze Ho, Vivian Yvonne Shin, Chun Hang Au, Wing Pan Luk, Ling Hiu Fung, Tsun‐Leung Chan, Karen Kar Loen Chan, Hextan Yuen Sheung Ngan, Edmond Shiu Kwan Ma
Molecular Genetics & Genomic Medicine.2022;[Epub]     CrossRef
PARP Inhibitors in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Meta-Analysis of Randomized Clinical Trials
Yizi Wang, Fang Ren, Zixuan Song, Xiaoying Wang, Chiyuan Zhang, Ling Ouyang
Frontiers in Oncology.2020;[Epub]     CrossRef